Roadmap Randomised Olmesartan and Diabetes Microalbuminuria Prevention Study
Trademark details
Roadmap Randomised Olmesartan and Diabetes Microalbuminuria Prevention Study® is a registered trademark used for Pharmaceutical Preparations For the Treatment of Cardiovascular Diseases, Circulatory Diseases, Urinary Diseases, Metabolic Diseases, Diabetic Nephropathy and Stroke Pharmaceutical and Scientific Research, Namely, Conducting Clinical Studies, Trials and Investigations and owned by Sankyo Company, Limited. Full trade mark registration details, registered images and more information below.
| Goods and/or Services: | Pharmaceutical Preparations For the Treatment of Cardiovascular Diseases, Circulatory Diseases, Urinary Diseases, Metabolic Diseases, Diabetic Nephropathy and Stroke Pharmaceutical and Scientific Research, Namely, Conducting Clinical Studies, Trials and Investigations |
| Serial Number: | 79003305 |
| Registration Number: | 3035932 |
| Filing Date: | May 19, 2004 |
|
Last Applicant(s)/ Owner(s) of Record | Sankyo Company, Limited5-1, Nihonbashi-Honcho 3-Chome |
| Related Products: | Pharmaceuticals, Miscellaneous Services; Scientific and technological services, and research and design relating thereto; Industrial analysis and research services; Design and development of computer hardware and software; Legal services |
Web Sites
powered by 
Total : 23,200 View more »
ROADMAP - InCirculation.net - cardiovascular medicine resources ...
Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study
Olmesartan Medoxomil in Diabetes Mellitus - Full Text View ...
... Masking: Double Blind (Subject, Investigator) Primary Purpose: Prevention: Official Title: Randomized Olmesartan and Diabetes Microalbuminuria Prevention Study (ROADMAP)
Preventing microalbuminuria in patients with diabetes: rationale ...
Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.
Olmesartan Associated with Prevention of Microalbuminuria in ...
This multinational trial, called the Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study, was conducted in centers across Europe and sponsored ...
